Metraipolis › archive › dc_afdf2195db63
Mast cell driven immunometabolism as a therapeutic entry point in ESCC — Europe PMC PMID:42199342
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42199342
- DOI
- 10.3389/fcell.2026.1830394
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T12:37:12.832Z
- SHA-256 of the archived text
7634014d7af64dd1048e040a91c49186c294f2fed15cc928fc1903ce7a574e0e- Stable URL of this page
https://metraipolis.com/documento/dc_afdf2195db63
How to cite
Mast cell driven immunometabolism as a therapeutic entry point in ESCC — Europe PMC PMID:42199342 — Europe PMC (en), https://europepmc.org/article/MED/42199342 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afdf2195db63 (Metraipolis archive dc_afdf2195db63, sha256 7634014d7af64dd1048e040a91c49186c294f2fed15cc928fc1903ce7a574e0e)
BibTeX
@misc{dcafdf2195db63,
title = {Mast cell driven immunometabolism as a therapeutic entry point in ESCC — Europe PMC PMID:42199342},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42199342},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afdf2195db63; sha256 7634014d7af64dd1048e040a91c49186c294f2fed15cc928fc1903ce7a574e0e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42199342. Agents can read the archived copy with the MCP tool read_document.